Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- Low FODMAPs Diet in IBS: Experts Disagree on Evidence of Efficacy
-
- Top 10 IBD Stories of 2015
- Use of Endoscopic Ultrasound for Patient Management Richard A. Kozarek, MD
- FDA Accepts Application of Cenicriviroc for Primary Sclerosing Cholangitis
- FDA Accepts Merck’s Biologics License Application for Bezlotoxumab
- FDA Approves Device to Treat Fecal Incontinence
- FDA Approves Olympus Duodenoscope Modifications
- FDA Approves Zepatier for HCV Genotypes 1, 4
- FDA Grants Priority Review of Sovaldi/velpatasvir for all HCV Genotypes
-
- The Diet Debate in IBS
- The Patient with Inflammatory Bowel Disease
- Updated ESPGHAN Guidelines: Infant Age at Gluten Introduction Does Not Affect Risk for Celiac Disease
- Colorectal Cancer Incidence Rising in Patients Younger Than Screening Age
- Dietary Fiber Associated With Reduced Crohn's Disease Flares
- Patients with IBS-D Benefit from Gluten-Free Diet
- Adjuvant Therapy Performed at High-Volume Center Improved OS in Pancreatic Cancer
- mFOLFOX7 Followed by mFOLFIRI May Improve Overall Survival in Advanced Gastric Cancer
-
- CarPac Preop Chemoradiation Benefits Patients with Resectable Esophageal Cancer
- Nivolumab Monotherapy Shows Promise in Treating Gastric, GE Junction Cancers
- T-DM1 not Superior to Taxane in HER-2–Positive Gastric, GE Junction Cancer
- Protagonist Begins Clinical Trial of Novel Oral Targeted Therapy for IBD
- Senate Report Pins ERCP Scope-Related 'Superbug' Outbreaks on FDA, Manufacturers, Hospitals